RE: Why have rampers gone wild?16 Dec 2024 08:54
There has been various updates about efficacy in the phase 1 trial this far.
Avacta biggest problem is being on AIM. the investment environment is awful in the UK but being on AIM doesn't help.
Listing on a US exchange won't be a silver bullet but I would welcome it. Dilution as well. Especially after that interview from the weekend.